U.S. Markets open in 5 hrs 3 mins

Should You Be Concerned About Dynavax Technologies Corporation’s (NASDAQ:DVAX) Historical Volatility?

Simply Wall St

Anyone researching Dynavax Technologies Corporation ( NASDAQ:DVAX ) might want to consider the historical volatility of the share price. Volatility is considered to be a measure of risk in modern finance theory. Investors may think of volatility as falling into two main categories. First, we have company specific volatility, which is the price gyrations of an individual stock. Holding at least 8 stocks can reduce this kind of risk across a portfolio. The second type is the broader market volatility, which you cannot diversify away, since it arises from macroeconomic factors which directly affects all the stocks on the market.

Some stocks see their prices move in concert with the market. Others tend towards stronger, gentler or unrelated price movements. Some investors use beta as a measure of how much a certain stock is impacted by market risk (volatility). While we should keep in mind that Warren Buffett has cautioned that ‘Volatility is far from synonymous with risk’, beta is still a useful factor to consider. To make good use of it you must first know that the beta of the overall market is one. A stock with a beta greater than one is more sensitive to broader market movements than a stock with a beta of less than one.

See our latest analysis for Dynavax Technologies

What does DVAX’s beta value mean to investors?

Looking at the last five years, Dynavax Technologies has a beta of 0.81. The fact that this is well below 1 indicates that its share price movements haven’t historically been very sensitive to overall market volatility. This suggests that including it in your portfolio will reduce volatility arising from broader market movements, assuming your portfolio’s weighted average beta is higher than 0.81. Share price volatility is well worth considering, but most long term investors consider the history of revenue and earnings growth to be more important. Take a look at how Dynavax Technologies fares in that regard, below.

NasdaqCM:DVAX Income Statement, March 1st 2019

Could DVAX’s size cause it to be more volatile?

Dynavax Technologies is a small company, but not tiny and little known. It has a market capitalisation of US$577m, which means it would be on the radar of intstitutional investors. Small companies often have a high beta value, but they can be heavily influenced by company-specific events. This might explain why this stock has a low beta.

What this means for you:

One potential advantage of owning low beta stocks like Dynavax Technologies is that your overall portfolio won’t be too sensitive to overall market movements. However, this can be a blessing or a curse, depending on what’s happening in the broader market. This article aims to educate investors about beta values, but it’s well worth looking at important company-specific fundamentals such as Dynavax Technologies’s financial health and performance track record. I urge you to continue your research by taking a look at the following:

  1. Future Outlook : What are well-informed industry analysts predicting for DVAX’s future growth? Take a look at our free research report of analyst consensus for DVAX’s outlook.
  2. Past Track Record : Has DVAX been consistently performing well irrespective of the ups and downs in the market? Go into more detail in the past performance analysis and take a look at the free visual representations of DVAX’s historicals for more clarity.
  3. Other Interesting Stocks : It’s worth checking to see how DVAX measures up against other companies on valuation. You could start with this free list of prospective options .

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com . This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.